Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilitiesCarl M. Gay, Lauren A. Byers, Elizabeth M. Park et al.|Cancer Cell|2021Cited by 930
Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapiesRobert J. Cardnell, Lauren A. Byers|Oncotarget|2017Cited by 92
Sepiapterin Ameliorates Chemically Induced Murine Colitis and Azoxymethane-Induced Colon CancerRobert J. Cardnell, Ross B. Mikkelsen|Journal of Pharmacology and Experimental Therapeutics|2013Cited by 18